Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Curevac Ag patents

Recent patent applications related to Curevac Ag. Curevac Ag is listed as an Agent/Assignee. Note: Curevac Ag may have other listings under different names/spellings. We're not affiliated with Curevac Ag, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Curevac Ag-related inventors




Date Curevac Ag patents (updated weekly) - BOOKMARK this page
11/16/17Ebolavirus and marburgvirus vaccines
09/21/17Vaccination in newborns and infants
09/07/17Polymeric carrier cargo complex for use as an immunostimulating agent or as an adjuvant
08/31/17Artificial nucleic acid molecules for improved protein or peptide expression
08/24/17Reversible immobilization and/or controlled relase of nucleic acid containing nanoparticles by (biodegradable) polymer coatings
08/03/17Respiratory syncytial virus (rsv) vaccine
07/27/17Immunostimulation by chemically modified rna
07/20/17Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
07/13/17Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
07/13/17Vaccination in newborns and infants
06/29/17Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
06/29/17Vaccination with mrna-coded antigens
05/11/17Complexes of rna and cationic peptides for transfection and for immunostimulation
04/27/17Methods and means for enhancing rna production
03/09/17Complexes of rna and cationic peptides for transfection and for immunostimulation
03/02/17Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
02/02/17Vaccine composition comprising complexed immunostimulatory nucleic acids and antigens packaged with disulfide-linked polyethyleneglycol/peptide conjugates
02/02/17Artificial nucleic acid molecules
01/19/17Combination of vaccination and ox40 agonists
01/05/17Complexes of rna and cationic peptides for transfection and for immunostimulation
01/05/17Combination therapy for immunostimulation
01/05/17Composition for treating prostate cancer (pca)
12/22/16Complexes of rna and cationic peptides for transfection and for immunostimulation
12/15/16Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
12/01/16Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
11/17/16Rna containing composition for treatment of tumor diseases
11/10/16Method for producing rna
11/03/16Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
11/03/16Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
10/20/16Composition for treating prostate cancer (pca)
10/20/16Artificial nucleic acid molecules
10/20/16Methods for rna analysis
09/01/16Nucleic acids comprising formula (nuglxmgnnv)a and derivatives thereof as immunostimulating agent/adjuvant
08/18/16Modified rna with decreased immunostimulatory properties
07/21/16Combination of vaccination and inhibition of the pd-1 pathway
07/21/16Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
06/30/16Complexes of rna and cationic peptides for transfection and for immunostimulation
06/30/16Rna-coded antibody
06/16/16Composition and vaccine for treating prostate cancer
06/16/16Combination vaccine
06/16/16Rna-coded antibody
06/16/16Rna-coded antibody
06/16/16Rna-coded antibody
06/16/16Method for increasing expression of rna-encoded proteins
06/16/16Rabies vaccine
06/16/16Respiratory syncytial virus (rsv) vaccine
06/16/16Composition and vaccine for treating lung cancer
06/16/16Rna-coded antibody
06/02/16Vaccination in elderly patients
06/02/16Rna-coded antibody
06/02/16Rna-coded antibody
05/26/16Rna-coded antibody
05/19/16Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
05/19/16Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
05/19/16Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
05/19/16Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
05/19/16Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
05/19/16Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
05/19/16Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
05/12/16Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
05/12/16Combination of vaccination and inhibition of the pd-1 pathway
04/07/16Application of mrna for use as a therapeutic against tumour diseases
04/07/16Application of mrna for use as a therapeutic against tumour diseases
03/31/16Application of mrna for use as a therapeutic against tumour diseases
03/31/16Application of mrna for use as a therapeutic against tumour diseases
Patent Packs
03/31/16Application of mrna for use as a therapeutic against tumour diseases







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Curevac Ag in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Curevac Ag with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';